It isn't impossible for cannabis stocks to report profits, but finding stocks in the industry that can do so consistently is another story. That's one of the reasons many investors steer clear of the industry, as a lack of profitability and lots of cash burn have made the sector a very risky one to invest in. Two Israeli companies are researching an exciting new technology that could change the outlook for the industry, which could help cannabis companies improve their margins.

A group of Italian researchers, led by Professor Giuseppe Cannazza of the University of Modena and Reggio Emilia (UniMore), has discovered a new cannabinoid more than 30 times more potent than THC. Upon discovery, they named it tetrohydrocannabiforol (Δ9-THCP) and isolated it along with a corresponding cannabidiol (CBD) homolog with a seven-term side alkyl chain, cannabidiforol (CBDP). 

The marijuana industry was supposed to have investors seeing green in 2019, but it's red that's dominated the landscape. Following a blazing first quarter which saw more than a dozen pot stocks rise by at least 70%, cannabis stocks spent the remaining nine months of the year in a precipitous downtrend.

While the industry clearly has a lot of growing up to do, there's also a massive long-term opportunity for investors to take advantage of. After all, Wall Street still sees the marijuana industry growing from nearly $11 billion in worldwide sales in 2018 to at least $50 billion in annual sales by 2030.

Since its mainstream introduction a couple of years ago, CBD has become one of the biggest disruptors in the beauty industry. The compound has been embraced by consumers of all kinds, causing beauty companies to look for original ways to make their mark on the blooming business. A new study predicts that by 2024, the CBD industry will be worth over 950$ billion.

This study was conducted by a strategic consultancy firm called Prohibition Partners, who called CBD’s breakthrough within the beauty industry unprecedented.

Winter gloom is a perennial phenomenon, thanks to shorter and darker, freezing-cold days, long nights, and an overall feeling of less energy. According to researchers, Seasonal Affective Disorder (SAD) impacts 14 percent of Americans. For many of us, this is more of a reality than we care to admit. When dreariness engulfs every part of our life, we feel the effects and toss our wellness out of the window by doing what feels good in the moment versus what’s good for us in the long term. 

Getting a high from using tetrahydrocannabinol (THC) is one of the key reasons people use marijuana. But the potency level of THC has been rising quickly over the years, and pot is much stronger than it was in the past. However, not everyone is looking to get as high as possible, and that's why there could be a more prominent trend among casual users: "lite" bud.

Company launches "LiteBud" brand

In January, Vireo Health (OTC:VREOF) announced it was launching a brand of products dubbed "LiteBud" in an attempt to meet the needs of consumers looking for a buzz as opposed to getting downright stoned.

Big Weed exists in the age of Big Data, meaning the cannabis industry is vulnerable to all the same attacks and hacks as everyone else.

CBD is helping to establish cannabis as a legitimate products in the wellness market.

CBD, the more commonly known name for cannabidiol, is one of more than a hundred compounds found in the cannabis plant, and while there are several perceptions within the public around the benefits of CBD consumption, the most widely known fact about CBD is that it is non-psychoactive.

It is estimated that as many as 88 percent of older individuals around the world suffer from chronic pain. It’s no secret that as the body ages, aches and pains become more common.

Chronic pain can be very miserable to live with and can have a debilitating impact on a person’s life.

One of those areas of everyday life is sleep. If you talk to anyone that suffers from chronic pain, they will be quick to tell you that it has a significantly negative impact on their ability to go to sleep and stay asleep at night.

According to a recent study, cannabis may be able to help.

After a very rough year in 2019 for most marijuana stocks, 2020 has started off on a better note overall. While some stocks continue to languish, others have bolted out of the gate.